天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2014年
5期
502-506
,共5页
薛敏敏%徐忠良%董公明%谢芳%吴佩群%白岚
薛敏敏%徐忠良%董公明%謝芳%吳珮群%白嵐
설민민%서충량%동공명%사방%오패군%백람
肝炎,乙型%肝硬化%转化生长因子β1%多态现象,遗传%Meta分析%基因多态性
肝炎,乙型%肝硬化%轉化生長因子β1%多態現象,遺傳%Meta分析%基因多態性
간염,을형%간경화%전화생장인자β1%다태현상,유전%Meta분석%기인다태성
hepatitis B%liver cirrhosis%transforming growth factor beta1%polymorphism,genetic%Meta-analysis%genetic polymorphism
目的:探索转化生长因子(TGF)-β1基因多态性与我国人群乙型肝炎肝硬化的关系。方法计算机检索中国生物医学文献数据库、重庆维普中文科技期刊全文数据库、清华CNKI数据库、万方科技期刊全文数据库、Pubmed,检索时间范围为建库到2013年7月。按纳入、排除标准选择TGF-β1基因509位点、869位点基因多态性与乙型肝炎肝硬化关系的病例对照研究。应用RevMan 5.1软件对纳入的研究进行定量分析。结果共纳入6个病例对照研究。Meta分析结果显示509位点携带T等位基因的乙型肝炎肝硬化合并OR值为1.02,95%CI为(0.67~1.54), CT和TT基因型者乙型肝炎肝硬化合并OR值为0.80,95%CI为(0.36~1.78);869位点携带C等位基因的乙型肝炎肝硬化的合并OR值为1.05,95%CI为(0.69~1.62),TC和CC基因型者乙型肝炎肝硬化的合并OR值为0.98,95%CI为(0.48~2.00)。未发现显著发表偏倚。结论未发现中国人群中TGF-β1基因多态性与乙型肝炎肝硬化有关系。
目的:探索轉化生長因子(TGF)-β1基因多態性與我國人群乙型肝炎肝硬化的關繫。方法計算機檢索中國生物醫學文獻數據庫、重慶維普中文科技期刊全文數據庫、清華CNKI數據庫、萬方科技期刊全文數據庫、Pubmed,檢索時間範圍為建庫到2013年7月。按納入、排除標準選擇TGF-β1基因509位點、869位點基因多態性與乙型肝炎肝硬化關繫的病例對照研究。應用RevMan 5.1軟件對納入的研究進行定量分析。結果共納入6箇病例對照研究。Meta分析結果顯示509位點攜帶T等位基因的乙型肝炎肝硬化閤併OR值為1.02,95%CI為(0.67~1.54), CT和TT基因型者乙型肝炎肝硬化閤併OR值為0.80,95%CI為(0.36~1.78);869位點攜帶C等位基因的乙型肝炎肝硬化的閤併OR值為1.05,95%CI為(0.69~1.62),TC和CC基因型者乙型肝炎肝硬化的閤併OR值為0.98,95%CI為(0.48~2.00)。未髮現顯著髮錶偏倚。結論未髮現中國人群中TGF-β1基因多態性與乙型肝炎肝硬化有關繫。
목적:탐색전화생장인자(TGF)-β1기인다태성여아국인군을형간염간경화적관계。방법계산궤검색중국생물의학문헌수거고、중경유보중문과기기간전문수거고、청화CNKI수거고、만방과기기간전문수거고、Pubmed,검색시간범위위건고도2013년7월。안납입、배제표준선택TGF-β1기인509위점、869위점기인다태성여을형간염간경화관계적병례대조연구。응용RevMan 5.1연건대납입적연구진행정량분석。결과공납입6개병례대조연구。Meta분석결과현시509위점휴대T등위기인적을형간염간경화합병OR치위1.02,95%CI위(0.67~1.54), CT화TT기인형자을형간염간경화합병OR치위0.80,95%CI위(0.36~1.78);869위점휴대C등위기인적을형간염간경화적합병OR치위1.05,95%CI위(0.69~1.62),TC화CC기인형자을형간염간경화적합병OR치위0.98,95%CI위(0.48~2.00)。미발현현저발표편의。결론미발현중국인군중TGF-β1기인다태성여을형간염간경화유관계。
Objective To evaluate the relationship between genetic polymorphism of transforming growth factor (TGF)-β1 and susceptibility of liver cirrhosis after hepatitis B virus infection in Chinese population. Methods CBM, VIP, CNKI, Wanfang technological periodical full-text databases and Pubmed from set up to July, 2013 were electronically searched to identify case-control studies on the relationship between genetic polymorphism of TGF-β1 promoter 509 site, co-don 869 site and liver cirrhosis after hepatitis B virus infection. The data were quantitatively analyzed by RevMan 5.1 soft-ware after assessing the quality of included studies. Results Six case-control studies were selected for Meta-analysis based on our inclusion and exclusion standards. The results of Meta-analysis showed that the pooled OR value for liver cir-rhosis among Chinese patients after hepatitis B virus infection with T allele of TGF-β1 gene at promoter 509 was 1.02 (95%CI:0.67-1.54), the pooled OR values for patients with TT and CT genotypes were 0.80 (95%CI:0.36-1.78). OR values for pa-tients with C allele of TGF-β1 gene at codon 869 was 1.05 (95%CI:0.69-1.62), the pooled OR values for patients with CC and CT genotypes were 0.98 (95%CI:0.48-2.00). No significant publication bias was found. Conclusion The genetic poly-morphism of TGF-β1 at promoter 509 and codon 869 showed no association with susceptibility of liver cirrhosis after hepati-tis B virus infection in Chinese population.